Skip to content

Single-cell Colorectal Cancer Atlas with 4.27M cells

Notifications You must be signed in to change notification settings

vjmarteau/crc-atlas

 
 

Repository files navigation

The single-cell Colorectal Cancer Atlas

Marteau, V., Nemati, N., Handler, K., Raju, D., Kvalem Soto, E., Fotakis, G., ... & Trajanoski, Z. (2024). High-resolution single-cell atlas reveals diversity and plasticity of tissue-resident neutrophils in colorectal cancer. bioRxiv. doi:10.1101/2024.08.26.609563

The single cell colorectal cancer atlas is a resource integrating more than 4.27 million cells from 650 patients across 49 studies (77 datasets) representing 7 billion expression values. These samples encompass the full spectrum of disease progression, from normal colon to polyps, primary tumors, and metastases, covering both early and advanced stages of CRC.

The atlas is publicly available for interactive exploration through a cell-x-gene instance. We also provide h5ad objects and a scArches model which allows to project custom datasets into the atlas. For more information, check out the

This repository contains the source-code to reproduce the single-cell data analysis for the paper. The analyses are wrapped into nextflow pipelines, all dependencies are provided as singularity containers, and input data are available from zenodo (coming soon).

For clarity, the project is split up into two separate workflows:

  • build_atlas: Takes one AnnData object with UMI counts per dataset and integrates them into an atlas.
  • downstream_analyses: Runs analysis tools on the annotated, integrated atlas and produces plots for the publication.

The build_atlas step requires specific hardware (CPU + GPU) for exact reproducibility (see notes on reproducibility) and is relatively computationally expensive. Therefore, the downstream_analysis step can also operate on pre-computed results of the build_atlas step, which are available from zenodo.

Structure of this repository

  • analyses: Place for e.g. jupyter/rmarkdown notebooks, gropued by their respective (sub-)workflows.
  • bin: executable scripts called by the workflow
  • conf: nextflow configuration files for all processes
  • containers: place for singularity image files. Not part of the git repo and gets created by the download command.
  • data: place for input data and results in different subfolders. Gets populated by the download commands and by running the workflows.
  • src: custom libraries and helper functions
  • modules: nextflow DSL2.0 modules
  • subworkflows: nextflow subworkflows
  • tables: contains static content that should be under version control (e.g. manually created tables)
  • workflows: the main nextflow workflows

Contact

For reproducibility issues or any other requests regarding single-cell data analysis, please use the issue tracker. For anything else, you can reach out to the corresponding author(s) as indicated in the manuscript.

Notes on reproducibility

We aimed to make this workflow reproducible by providing all input data, containerizing dependencies, and integrating all analysis steps into a Nextflow workflow. This setup allows execution on any system that can run Nextflow and Singularity. However, certain single-cell analysis algorithms like scVI/scANVI and UMAP may yield slightly different results depending on hardware, with variations in cores or CPU/GPU architecture affecting results. For details, see this discussion.

Since cell-type annotations depend on clustering and the scANVI embedding, running build_atlas on different hardware may alter cell-type labels.

Below is the hardware used to execute the build_atlas workflow. While results should be consistent across CPUs/GPUs of the same generation, this has not been tested.

  • Compute node CPU: Intel(R) Xeon(R) Gold 6342 CPU @ 2.80GHz (2x)
  • GPU node GPU: NVIDIA A100 80GB PCIe

About

Single-cell Colorectal Cancer Atlas with 4.27M cells

Resources

Stars

Watchers

Forks

Releases

No releases published

Packages

No packages published

Languages

  • Python 91.9%
  • Nextflow 7.4%
  • Other 0.7%